Related Experiment Videos

Type beta transforming growth factor is a potent inhibitor of murine megakaryocytopoiesis in vitro

Blood
|June 1, 1987
PubMed

Insights

Platelets, specifically transforming growth factor beta (TGF-beta), inhibit megakaryocytopoiesis. This growth factor potently suppresses megakaryocytic differentiation in murine marrow cultures, impacting cell growth and colony formation.

Area of Science:

  • Hematology
  • Cell Biology
  • Developmental Biology

Background:

  • Platelets are known to contain growth factors, including transforming growth factor beta (TGF-beta).
  • The role of platelets and TGF-beta in regulating megakaryocytopoiesis, the process of megakaryocyte development, is not fully understood.

Purpose of the Study:

  • To investigate the inhibitory effect of human platelet extracts on murine megakaryocytopoiesis in vitro.
  • To determine if transforming growth factor beta (TGF-beta) is the active component responsible for platelet-induced inhibition.
  • To characterize the specific effects of TGF-beta on megakaryocytic differentiation and proliferation.

Main Methods:

  • Serumless liquid cultures of murine bone marrow were treated with freeze-thawed human platelet extracts.
  • Acetylcholinesterase (AchE) activity, a marker for megakaryocytic differentiation, was measured.
  • Purified TGF-beta and mitogen-stimulated conditioned medium were added to cultures to assess their inhibitory effects.
  • Isolated megakaryocytes were cultured with interleukin 3 (IL3) and TGF-beta to evaluate specific differentiation aspects.
  • Colony assays were performed to assess the impact on megakaryocytic and granulocyte-macrophage progenitor cells.

Main Results:

  • Platelet extracts significantly inhibited AchE activity at concentrations above 5 X 10(6) platelets/mL.
  • Freeze-thawed granulocyte extracts showed less inhibition compared to platelet extracts.
  • TGF-beta demonstrated potent inhibition of AchE activity, with 50% inhibition at 4 pmol/L.
  • TGF-beta reduced the proportion of IL3-induced differentiating megakaryocytes from 68% to 20%.
  • Picomolar concentrations of TGF-beta inhibited both megakaryocytic and granulocyte-macrophage colony formation.

Conclusions:

  • TGF-beta is a potent inhibitor of murine megakaryocytopoiesis in vitro.
  • Platelets may regulate megakaryocytopoiesis through the release of TGF-beta.
  • TGF-beta's inhibitory effects extend beyond the megakaryocytic lineage, affecting other hematopoietic progenitors.

Related Concept Videos